2020 THSNA: April 23-25, 2019 in Chicago with Abstract Submission Deadline of December 13, 2019
Online abstract submission is now open for the 2020 Thrombosis & Hemostasis Summit of North American (THSNA), and all submissions are due December 13, 2019. They will be considered for either a digitial poster presentation and/or short oral presentation in each of the following program tracks: Thrombosis, Hemostasis, Laboratory, and Basic Science.
THSNA brings together the leading hemostasis and thrombosis organizations and experts to provide insight on improving patient care. This year's Summit will highlight basic science, clinical, and laboratory inforamtion that reflects the latest understanding of bleeding and clotting disorders. For full invitation to submit, CLICK HERE.
For more info, CLICK HERE
To visit the THSNA 2020 Summit website, CLICK HERE
HTRS Member Spotlight Q&A: HTRS 2019 Lifetime Achievement Awardees Drs. M. Elaine Eyster and Victor Blanchette Receive Distinction
To honor their outstanding career contributions to the field of hemostasis and thrombosis, Drs. M. Elaine Eyster and Victor Blanchette each received a 2019 HTRS Lifetime Achievement Award, bestowed at the HTRS/NASTH 2019 Scientific Symposium in New Orleans, LA this past May. Dr. Victor S. Blanchette, MD (pictured left), is Medical Director of the Pediatric Thrombosis and Hemostasis Program at the Hospital for Sick Children, Toronto, and Professor of Pediatrics at the University of Toronto, Canada. Dr. M. Elaine Eyster, MD, FACP (pictured above), is Distinguished Professor of Medicine at the Penn State Health Milton S. Hershey Medical Center and Penn State College of Medicine. Get to know them better...click below!
DR. M. ELAINE EYSTER Q&A: CLICK HERE
DR. BLANCHETTE Q&A: CLICK HERE
Special Tribute to Joan Cox Gill, MD
In honor of Joan Cox Gill, MD, HTRS co-founder and longtime Board Treasurer, an Eastern red bud tree was planted outside Versiti's Comprehensive Center for Bleeding Disorders (CCBD) on August 12, 2019. Family, friends, and Versiti colleagues gathered to honor Dr. Gill's legacy and her years of dedicated service to the hemostasis/thrombosis community. Picnic tables will be added to the area around the tree, creating an outdoor space for CCBD staff to enjoy for years to come.
Special thanks to the following HTRS members for making this wonderful tribute possible: Lynn Malec, MD, MSc, current HTRS Treasurer and CCBD Medical Director; CCBD Manager Tiffini Mueller, RN, BSN; and Gilbert C. White, II, MD, MS, Versiti's Executive Vice President of Research and Director of the Versiti Blood Research Institute.
Exciting NHLBI News: Blueprint, Strategies and Tools for Future Factor VIII Inhibitor-Related Research
Factor VIII Inhibitor State of the Science Workshop Proceedings have been published in the July 2019 edition of Hemophilia - Volume 24, Issue 4.
For more info, CLICK HERE.
Abstracts from 2019 Symposium published in Haemophilia
The Abstracts from the HTRS/NASTH 2019 Scientific Symposium are now published in Haemophilia, the official journal of HTRS.
For more info, CLICK HERE.
Podcast: NHLBI Resources and Grants for Hematologists with Drs. DiMichele and Hoots
How to maximize research training and funding opportunities for non-malignant hematology and blood science investigators is the subject of this free podcast, in which Dr. Donna DiMichele and Dr. Keith Hoots of the National Heart, Lung, and Blood Institute (NHLBI) talk about NHLBI and National Institutes of Health resources and grants available to hematologists.
For more info, CLICK HERE.
Apply for a Grant
.THSNA Travel-to-a-Mentor Award
.
2019 HTRS Annual Business Meeting: June 10, 2019
The 2018 HTRS Annual Business Meeting webinar and slides are available to HTRS members for viewing in the members-only section on the HTRS website.
Join a Registry
The Children’s Hospital-Acquired Thrombosis (CHAT) Study
2020 HTRS Student Research Awards Call for Applications: Online submission site now open
Applications are now open for the Hemostasis and Thrombosis Research Society (HTRS) Student Research Award, an 8- to 10-week program for medical, PhD, MD/PhD, or PharmD students working on targeted research projects in hemostasis and thrombosis. Proposed projects may be lab-based, clinical or epidemiologic in design. The program includes a $5,000 award stipend plus a $2,000 travel allowance, collaboration with a research mentor, and a presentation at a 2021 professional meeting.
With a launch of November 1, 2019, applicants may begin applying at https://htrs.smapply.org. The application deadline is March 2, 2020 by 11:59 p.m. ET.
For more details, see the Request for Proposals: CLICK HERE
2020 ITI School in Hemophilia Call for Applications: Due Nov 18, 2019 for Jan 2020 Course in Malmö
HTRS has been commissioned by Octapharma to recruit and select up to three U.S. hematologists to attend ITI School in Hemophilia from January 17-18, 2020, in Malmö, Sweden.
This educational course is sponsored by Octapharma and provided by Lund University and the Malmö Centre for Thrombosis and Haemostasis at Skåne University Hospital in collaboration with international hemophilia experts, including HTRS Member Robert F. Sidonio, Jr., MD, Associate Director of the Hemostasis and Thrombosis Program at Children's Healthcare of Atlanta, and Director of Clinical Operations and Clinical Research of the Hemostasis and Thrombosis Program, Aflac Cancer and Blood Disorders Center, Atlanta, GA.
We are seeking applications from U.S. hematologists who can demonstrate a need for further training in the best approaches and care of hemophilia patients who develop inhibitors. Participants should be affiliated with a hemophilia treatment center and have previous ITI experience.
The deadline is Monday, November 18, 2019, by 11:59 PM ET. Submit applications via our Online Grant Submission site: https://htrs.smapply.org. Please scroll to the bottom of the page for the ITI Course in Hemophilia Program, look to the right, and click MORE.
Applications will open soon for the Hemostasis and Thrombosis Research Society (HTRS) Student Research Award, an 8- to 10-week program for medical, PhD, MD/PhD, or PharmD students working on targeted research projects in hemostasis and thrombosis. Proposed projects may be lab-based, clinical or epidemiologic in design. The program includes a $5,000 award stipend plus a $2,000 travel allowance, collaboration with a research mentor, and a presentation at a 2021 professional meeting.
For further details, CLICK HERE.
For more details, see the Request for Proposals: CLICK HERE
The Online Application Form is available HERE
ITI COURSE FLYER
ITI COURSE DESCRIPTION
ITI PROGRAM AGENDA
Announcing 2020 HTRS/Novo Nordisk Clinical Fellowship Award (CFA) in Hemophilia and Rare Bleeding Disorders
HTRS and Novo Nordisk Inc. announce the availability of one Clinical Fellowship Award (CFA) in 2020 focused on hemophilia and rare bleeding disorders for one academic year (July 1, 2020 - June 30, 2021). During the fellowship year, the awardee must be mentored by an experienced MD, MD/PhD or DO working in hemophilia or rare bleeding disorders at an established U.S.-based hemostasis treatment center (HTC).
The deadline is January 31, 2020, by 11:59 PM ET. Submit applications via our Online Grant Submission site: https://htrs.smapply.org. Please scroll to the bottom of the page for the HTRS/Novo Nordisk CFA Program, look to the right, and click on MORE.
For more details, see the Request for Proposals: CLICK HERE
The online Application Form is available HERE
This 2020 award is supported by an educational grant from Novo Nordisk Inc.
Earl W. Davie Symposium: November 2019, Vancouver
The University of British Columbia Centre for Blood Research presents the Earl W. Davie Symposium on November 13, 2019 in Vancouver, Canada. Trainee Travel/Accommodation Awards are available.
For more information, CLICK HERE.
To register, CLICK HERE.
2020 HTRS Research Colloquium: Registration now open
Join us for our second biennial Research Colloquium, a dynamic meeting focused on professional development and networking in benign hematology for:
- Basic Scientists
- Translational Researchers
- Clinicians/Physician-Scientists
Date and Location: April 21-22, 2020 at the Hyatt Regency Chicago
Travel Awards are available for residents, post-docs, fellows, instructors and junior faculty within seven years of completing fellowship.
READ MORE
For more info, visit the Colloquium website at https://www.eiseverywhere.com/website/4770/home/
SAVE THE DATES!
2020 HTRS Research Colloquium
April 21-22, 2020: Pre-THSNA 2020 Summit, Hyatt Regency, Chicago
The HTRS Research Colloquium targets junior faculty and early-stage investigators (MDs, DOs, MD/PhDs, and PhDs) who have completed fellowship and/or postdoctoral training and are working to build sustainable academic research careers in hemostasis and thrombosis. Third- or fourth-year medical fellows and/or postdocs may apply to attend if they can demonstrate an established commitment to building a research career in hemostasis or thrombosis upon completion of training. Travel awards are available for early-stage investigators upon application.
2020 THSNA Summit
April 22-25, 2020: Sheraton Hotel, Chicago IL
2021 HTRS Scientific Symposium
March 11-13, 2021: Loews Coronado Bay, San Diego, CA
World Thrombosis Day ("WTD"): Sunday, October 13
About 900,000 people in the U.S. alone are affected by blood clots each year, and about 100,000 of those will die -- greater than the total number of people who lose their lives each year to AIDS, breast cancer, and motor vehicle crashes combined. Even more startling: around the world, one in four people worldwide are suffering and dying from conditions caused by thrombosis, according to the WTD website.
We would like to thank our HTRS member physician scientists, PhD investigators, thrombosis nurses, and all allied health professionals whose career passions revolve around advancing research and clinical treatment for patients with thrombosis. Specially, we acknowledge HTRS Director Mary Cushman, MD, MSc, who recently helped moderate the World Thrombosis Day 2019 Webinar co-hosted by International Society on Thrombosis and Haemostasis (ISTH) and the Centers for Disease Control and Prevention (CDC). The topic was "Top 3 Considerations for the Prevention of Hospital-Associated VTE."
If you'd like to join the WTD movement and/or find a local event taking place this Sunday, 10/13, visit www.worldthrombosisday.org/action/partners.
To stay informed, CLICK HERE.
HTRS/NASTH 2019 Scientific Symposium: For CME credits, attendees should use form and passcode
On the last day of the meeting, attendees received the electronic form and passcode from the [email protected] email account twice following the meeting -- which are needed to get CME credits. For more info, contact [email protected] directly.
This was the 11th Symposium of the Hemostasis and Thrombosis Research Society (HTRS), and the first in which NASTH partnered with us. Our organizations brought together leading basic and translational science investigators with clinical colleagues for a dynamic meeting featuring:
- State-of-the-Art Lectures and Scientific Sessions
- Collaboration and networking
- Oral Abstract Presentations and Poster Sessions
- Career Development Breakfasts for early career investigators
Thanks to the HTRS/NASTH 2019 Symposium Sponsors, Exhibitors, and Medical Education Supporters:
Sponsors
Bayer, BPL, Cincinnati Children's Hospital, CSL Behring, Genentech, HTRS Members who Donated to the 2018 Annual Appeal, Octapharma, Pfizer, Sanofi Genzyme, Sebia, Takeda, Tremeau Pharmaceuticals, uniQure Inc.
Exhibitors
Alnylam Pharmaceuticals, Bayer, BioMarin Pharmaceutical, BMS/Pfizer, BPL, CSL Behring, CSL Behring Medical Affairs, Foundation for Women and Girls with Blood Disorders, Genentech, Grifols USA, LLC, Hemophilia Alliance, Kedrion Biopharma Inc., Machaon Diagnostics, Novo Nordisk Inc., Pfizer, Red Chip Enterprises, Sanofi Genzyme, Takeda, Takeda Medical Affairs, Tremeau Pharmaceuticals, Versiti
Medical Education Grants
Bayer, CSL Behring, Genentech, Grifols USA, Inc., Pfizer, Portola Pharmaceuticals, Inc.